Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Value of Combined [18F]Fluoro-2-deoxy-D-glucose (FDG) PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Potentially Operable Locally Advanced Head and Neck Squamous Cell Carcinoma.

NCT01179360 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT01179360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01179360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Value of Combined [18F]Fluoro-2-deoxy-D-glucose (FDG) PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Potentially Operable Locally Advanced Head and Neck Squamous Cell Carcinoma.
Lead sponsor
University Hospital, Antwerp
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
December 31, 2015
Enrollment
152 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced squamous cell carcinoma of the head and neck region